Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial
Titel:
Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial
Auteur:
Lheureux, Stephanie Cristea, Mihaela C Bruce, Jeffrey P Garg, Swati Cabanero, Michael Mantia-Smaldone, Gina Olawaiye, Alexander B Ellard, Susan L Weberpals, Johanne I Wahner Hendrickson, Andrea E Fleming, Gini F Welch, Stephen Dhani, Neesha C Stockley, Tracy Rath, Prisni Karakasis, Katherine Jones, Gemma N Jenkins, Suzanne Rodriguez-Canales, Jaime Tracy, Michael Tan, Qian Bowering, Valerie Udagani, Smitha Wang, Lisa Kunos, Charles A Chen, Eric Pugh, Trevor J Oza, Amit M